TL;DR
This study reveals that HIV-infected T cells can persist and even traffic between the blood and cerebrospinal fluid (CSF) in people living with HIV (PWH) on antiretroviral therapy (ART). By analyzing single-cell transcriptomes and T cell receptor (TCR) sequences, researchers found that these infected cells, primarily CD4 central memory T cells, are more abundant in the CSF for some individuals, suggesting the central nervous system (CNS) harbors a significant reservoir.
What Problem Does This Paper Address?
Despite effective antiretroviral therapy (ART), HIV establishes persistent reservoirs in various anatomical sites, including the central nervous system (CNS). Understanding the dynamics of this CNS reservoir is crucial for developing strategies to cure HIV. While it's known that HIV seeds the CNS early in infection and infected cells can persist there even during ART, the exact nature of these cells, their location within the CNS, and how they interact with the peripheral blood reservoir remain unclear. This paper aims to shed light on these questions by investigating the transcriptional states and clonal relationships of HIV-infected T cells in both the CSF and blood of PWH on ART.
Methods
The researchers employed a powerful combination of single-cell RNA sequencing (scRNA-Seq) and T cell receptor (TCR) sequencing. This dual approach allowed them to:
- Profile individual cells: scRNA-Seq provided detailed information about the gene expression of each cell, helping to identify cell types and their functional states.
- Track T cell clones: TCR sequencing enabled the identification of unique T cell receptors, allowing researchers to trace the lineage and expansion of specific T cell clones across different tissue compartments (blood and CSF).
- Detect HIV RNA: By aligning sequencing reads to the HIV-1 genome, they could identify cells actively transcribing viral RNA, indicating the presence of transcriptionally active viral reservoirs.
This paired approach is a significant advancement, enabling a high-resolution view of both the cellular and clonal landscape of HIV persistence.
Datasets
The study utilized samples from:
- 8 people living with HIV (PWH):
- 1 individual (P1) was ART-naive and diagnosed with AIDS, sampled longitudinally before and at multiple time points after ART initiation.
- 7 individuals (P2-P8) were on stable suppressive ART for an average of 16 years.
- 6 HIV-uninfected individuals: Used as controls.
Paired blood and cerebrospinal fluid (CSF) samples were collected from all participants.
Key Insights and Ideas
- CNS as a significant reservoir: The study found that HIV-1 RNA-containing cells were more frequent in the CSF than in the blood for some PWH, suggesting a higher burden of infected reservoir cells in the CNS.
- CD4 central memory T cells are key players: The majority of HIV-1 RNA-containing cells were identified as CD4 central memory T cells (TCM), highlighting their critical role in harboring the virus within the CNS.
- T cell trafficking between compartments: A notable finding was that some infected T cell clones were found in both the CSF and blood, indicating that these infected cells can traffic between these tissue compartments.
- Clonal expansion contributes to the reservoir: The presence of shared infected clones across compartments, and evidence of clonal expansion within these shared clones, suggests that the maintenance and expansion of these infected T cell clones contribute to the persistence of the HIV reservoir in the CNS, even during ART.
Key Results
- HIV RNA detection: HIV-1 transcripts were detected in 85 cells (0.03% of all cells analyzed) across blood and CSF samples from PWH.
- Predominance in CD4 TCM: 83.6% of infected CD4 T cells were identified as CD4 central memory T cells (TCM).
- Compartment-specific vs. shared clones: Of the infected CD4 T cell clones identified, 78% were compartment-specific (found only in CSF or blood), while 22% were found in both CSF and blood.
- Clonal expansion evidence: 28% of infected CD4 T cell clones showed evidence of clonal expansion, with some rare clones having detectable HIV RNA in both blood and CSF.
- ART's impact on clonality: Longitudinal analysis of one participant showed that ART initiation led to a contraction of expanded clones in both blood and CSF, though the contraction was less pronounced in the CSF, suggesting ongoing antigen stimulation in the CNS.
Limitations and Future Work
The authors acknowledge several limitations:
- Rarity of infected cells: The low frequency of HIV-1 RNA+ cells makes it challenging to fully characterize their properties and dynamics.
- Technical limitations: The 10x sequencing platform does not yield full-length viral sequences, limiting the ability to assess HIV splicing dynamics and replication competence.
- Potential for technical artifacts: The detection of HIV reads in some non-CD4 immune cells could be due to inherent phagocytic capabilities or technical issues like multiplets.
- Limited antigen specificity data: Publicly available TCR-antigen databases could only annotate a small percentage of TCR sequences, limiting the ability to determine the specific antigens targeted by persistent TCR clones.
- CSF as a proxy: While CSF is accessible, it may not fully represent the entire complexity of the viral reservoir in the brain.
Future work could focus on developing computational tools to infer antigen specificity from TCR sequences, further investigating the clinical factors influencing T cell trafficking and clonal expansion, and exploring novel therapeutic strategies targeting these persistent CNS reservoirs.
Summary updated